ExodusPoint Capital Management’s Quantum Biopharma Class B Subordinate Voting Shares QNTM Stock Holding History

ExodusPoint Capital Management’s Portfolio QNTM Stock Details QNTM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-266	Closed	-$15K	–	2544
2022 Q1	$15K	Buy	+266	New	+$16.1K	﹤0.01%	2112

Other funds holding QNTM

AdvisorShares Investments Bethesda, Maryland $549M AUM 32.58% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return

Rockefeller Capital Management New York $56.4B AUM 24.96% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

ExodusPoint Capital Management's QNTM Position: Q2 2022 in Review

ExodusPoint Capital Management sold out of Quantum Biopharma Class B Subordinate Voting Shares (QNTM) in Q2 2022, closing a stake of 266 shares — an estimated $15K sold.

ExodusPoint Capital Management first reported a position in QNTM in Q1 2022 and held it in 1 quarter. The position peaked at $15K in Q1 2022. 17 funds tracked by Wall St. Rank hold QNTM as of Q2 2022.

ExodusPoint Capital Management reported no remaining Quantum Biopharma Class B Subordinate Voting Shares position as of Q2 2022 after selling out during the quarter.
ExodusPoint Capital Management sold 266 Quantum Biopharma Class B Subordinate Voting Shares shares in Q2 2022, an estimated $15K.
ExodusPoint Capital Management first reported a position in Quantum Biopharma Class B Subordinate Voting Shares in Q1 2022 and held it in 1 quarter.
ExodusPoint Capital Management's Quantum Biopharma Class B Subordinate Voting Shares position peaked at $15K in Q1 2022.
17 funds tracked by Wall St. Rank held Quantum Biopharma Class B Subordinate Voting Shares as of Q2 2022.

Based on ExodusPoint Capital Management's 13F filing for Q2 2022, filed 22 Aug 2022.